NCT03181477View on ClinicalTrials.gov

Study Evaluating the Efficacy of Radiotherapy With SIB-IMRT, Associated With Temozolomide in Glioblastomas

NAActive, not recruitingINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

April 7, 2017

Primary Completion Date

September 2, 2023

Study Completion Date

September 2, 2025

Conditions
Glioblastoma, Adult
Interventions
DEVICE

Radiotherapy

Radiotherapy of 80 GY + Chemotherapy (Temozolomide)

Trial Locations (7)

21850

Centre Georges François Leclerc, Dijon

67000

Paul Strauss, Strasbourg

80054

CHU Amiens Picardie, Amiens

Unknown

CHU Besançon, Besançon

Centre d'oncologie et de radiothérapie, Mâcon

Institut de cancérologie de Lorraine, Nancy

Centre de cancérologie des dentellières, Valenciennes

All Listed Sponsors
lead

Centre Georges Francois Leclerc

OTHER

NCT03181477 - Study Evaluating the Efficacy of Radiotherapy With SIB-IMRT, Associated With Temozolomide in Glioblastomas | Biotech Hunter | Biotech Hunter